Paul Boughton
Only six months after launchWiley-VCH’s Biotechnology Journal is covered by PubMed/Medline.
Papers are now being invited to be submitted for forthcoming special issues devoted to biopharmaceutical technologymulti-enzyme systemsdrug targeting and energy production (reviewsoriginal research and Forum columns).
MeanwhileChemical Engineering & Technology has proven to be a reliable host for first class information and cutting edge research results in the field of chemical engineering.
Special issues in 2007 include micro reaction technologywhite biotechnology and high pressure technology.
Wiley-VCH Verlag GmbH & Co KGaA is based in WeinheimGermany. www.biotechnology-journal.com ; www.interscience.wiley.com
"